anmelden
GSK Aktie
21,67
EUR
-0,15
EUR
-0,69
%
20,15
CHF
-0,09
CHF
-0,44
%
GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 88,93 Mrd. EUR
KGV 12,93 Div. Rendite 3,62%WKN A3DMB5
ISIN GB00BN7SWP63
Symbol GLAXF
AI Analyse
Werbung
GSK Aktie Analyse
| 28.08.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.08.12 | GSK hold | Deutsche Bank AG | |
| 24.08.12 | GSK outperform | Exane-BNP Paribas SA | |
| 23.08.12 | GSK buy | Citigroup Corp. | |
| 20.08.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 16.08.12 | GSK neutral | Goldman Sachs Group Inc. | |
| 15.08.12 | GSK neutral | Nomura | |
| 03.08.12 | GSK halten | Independent Research GmbH | |
|
Werbung
|
|||
| 31.07.12 | GSK buy | Banc of America Securities-Merrill Lynch | |
| 27.07.12 | GSK buy | UBS AG | |
| 26.07.12 | GSK buy | UBS AG | |
| 26.07.12 | GSK neutral | Sarasin Research | |
| 26.07.12 | GSK equal-weight | Morgan Stanley | |
| 26.07.12 | GSK outperform | Exane-BNP Paribas SA | |
| 26.07.12 | GSK hold | Deutsche Bank AG | |
| 26.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 19.07.12 | GSK outperform | Exane-BNP Paribas SA | |
| 19.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 18.07.12 | GSK buy | Banc of America Securities-Merrill Lynch | |
| 18.07.12 | GSK neutral | Credit Suisse Group | |
| 18.07.12 | GSK neutral | Nomura | |
| 17.07.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 17.07.12 | GSK halten | Independent Research GmbH | |
| 17.07.12 | GSK neutral | Sarasin Research | |
| 13.07.12 | GSK hold | Deutsche Bank AG | |
| 12.07.12 | GSK neutral | J.P. Morgan Cazenove | |
| 10.07.12 | GSK buy | UBS AG | |
| 09.07.12 | GSK halten | Independent Research GmbH | |
| 05.07.12 | GSK hold | Deutsche Bank AG | |
| 03.07.12 | GSK buy | Citigroup Corp. | |
| 03.07.12 | GSK neutral | J.P. Morgan Cazenove | |
| 03.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 28.06.12 | GSK hold | Deutsche Bank AG | |
| 21.06.12 | GSK neutral | Credit Suisse Group | |
| 20.06.12 | GSK buy | Citigroup Corp. | |
| 19.06.12 | GSK outperform | Exane-BNP Paribas SA | |
| 11.06.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 08.06.12 | GSK buy | Citigroup Corp. | |
| 07.06.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 05.06.12 | GSK neutral | Credit Suisse Group | |
| 04.06.12 | GSK buy | Citigroup Corp. | |
| 31.05.12 | GSK buy | UBS AG | |
| 30.05.12 | GSK hold | Deutsche Bank AG | |
| 10.05.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 04.05.12 | GSK neutral | J.P. Morgan Cazenove | |
| 04.05.12 | GSK halten | Independent Research GmbH | |
| 02.05.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 26.04.12 | GSK neutral | Sarasin Research | |
| 23.04.12 | GSK neutral | Nomura | |
| 11.04.12 | GSK buy | UBS AG | |
Werbung
Werbung
